Gregory D. Davis

Insider Reports History

Entity
Individual
Location
C/O Sangamo Therapeutics, Inc., 501 Canal Blvd., Richmond, CA
Signature
/s/ Ron A. Metzger, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Gregory D. Davis:

Stock Role Class Num Shares Value Price $ Report Date Ownership
SANGAMO THERAPEUTICS, INC Head of Research & Technology Common Stock 203K $175K $0.86 Oct 18, 2024 Direct

Insider Reports Filed by Gregory D. Davis

Symbol Company Period Transactions Value $ Form Type Date Filed Role
SGMO SANGAMO THERAPEUTICS, INC Oct 18, 2024 0 $0 3 Oct 28, 2024 Head of Research & Technology